Scrape NSF SBIR Microbiome Award Database for Competitive Intelligence
- Organization
- NSF SBIR award publication system that leaks detailed technical abstracts without competitive analysis
- Sector
- Contract Research Organizations, venture capitalists, and competitive intelligence firms in biotech
- Location
- United States (NSF database)
Source reference
Executive summary
Current state
NSF awarded $305,000 SBIR Phase I funding to ENDURE BIOTHERAPEUTICS for a PKU microbiome therapeutic platform, creating a 6-month window where the company must prove technical feasibility but lacks strategic guidance, vendor intelligence, and IP protection for the critical Phase II transition required for survival.
Market catalyst
The NSF publishes detailed SBIR award abstracts with technical specifics but provides no centralized database for competitors or vendors to identify all companies working on similar therapeutic approaches. This creates information asymmetry where companies like ENDURE cannot easily see their competitive landscape.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.